Cargando…
Preference for biological motion is reduced in ASD: implications for clinical trials and the search for biomarkers
BACKGROUND: The neurocognitive mechanisms underlying autism spectrum disorder (ASD) remain unclear. Progress has been largely hampered by small sample sizes, variable age ranges and resulting inconsistent findings. There is a pressing need for large definitive studies to delineate the nature and ext...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8672507/ https://www.ncbi.nlm.nih.gov/pubmed/34911565 http://dx.doi.org/10.1186/s13229-021-00476-0 |
_version_ | 1784615368346566656 |
---|---|
author | Mason, L. Shic, F. Falck-Ytter, T. Chakrabarti, B. Charman, T. Loth, E. Tillmann, J. Banaschewski, T. Baron-Cohen, S. Bölte, S. Buitelaar, J. Durston, S. Oranje, B. Persico, A. M. Beckmann, C. Bougeron, T. Dell’Acqua, F. Ecker, C. Moessnang, C. Murphy, D. Johnson, M. H. Jones, E. J. H. |
author_facet | Mason, L. Shic, F. Falck-Ytter, T. Chakrabarti, B. Charman, T. Loth, E. Tillmann, J. Banaschewski, T. Baron-Cohen, S. Bölte, S. Buitelaar, J. Durston, S. Oranje, B. Persico, A. M. Beckmann, C. Bougeron, T. Dell’Acqua, F. Ecker, C. Moessnang, C. Murphy, D. Johnson, M. H. Jones, E. J. H. |
author_sort | Mason, L. |
collection | PubMed |
description | BACKGROUND: The neurocognitive mechanisms underlying autism spectrum disorder (ASD) remain unclear. Progress has been largely hampered by small sample sizes, variable age ranges and resulting inconsistent findings. There is a pressing need for large definitive studies to delineate the nature and extent of key case/control differences to direct research towards fruitful areas for future investigation. Here we focus on perception of biological motion, a promising index of social brain function which may be altered in ASD. In a large sample ranging from childhood to adulthood, we assess whether biological motion preference differs in ASD compared to neurotypical participants (NT), how differences are modulated by age and sex and whether they are associated with dimensional variation in concurrent or later symptomatology. METHODS: Eye-tracking data were collected from 486 6-to-30-year-old autistic (N = 282) and non-autistic control (N = 204) participants whilst they viewed 28 trials pairing biological (BM) and control (non-biological, CTRL) motion. Preference for the biological motion stimulus was calculated as (1) proportion looking time difference (BM-CTRL) and (2) peak look duration difference (BM-CTRL). RESULTS: The ASD group showed a present but weaker preference for biological motion than the NT group. The nature of the control stimulus modulated preference for biological motion in both groups. Biological motion preference did not vary with age, gender, or concurrent or prospective social communicative skill within the ASD group, although a lack of clear preference for either stimulus was associated with higher social-communicative symptoms at baseline. LIMITATIONS: The paired visual preference we used may underestimate preference for a stimulus in younger and lower IQ individuals. Our ASD group had a lower average IQ by approximately seven points. 18% of our sample was not analysed for various technical and behavioural reasons. CONCLUSIONS: Biological motion preference elicits small-to-medium-sized case–control effects, but individual differences do not strongly relate to core social autism associated symptomatology. We interpret this as an autistic difference (as opposed to a deficit) likely manifest in social brain regions. The extent to which this is an innate difference present from birth and central to the autistic phenotype, or the consequence of a life lived with ASD, is unclear. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13229-021-00476-0. |
format | Online Article Text |
id | pubmed-8672507 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-86725072021-12-15 Preference for biological motion is reduced in ASD: implications for clinical trials and the search for biomarkers Mason, L. Shic, F. Falck-Ytter, T. Chakrabarti, B. Charman, T. Loth, E. Tillmann, J. Banaschewski, T. Baron-Cohen, S. Bölte, S. Buitelaar, J. Durston, S. Oranje, B. Persico, A. M. Beckmann, C. Bougeron, T. Dell’Acqua, F. Ecker, C. Moessnang, C. Murphy, D. Johnson, M. H. Jones, E. J. H. Mol Autism Research BACKGROUND: The neurocognitive mechanisms underlying autism spectrum disorder (ASD) remain unclear. Progress has been largely hampered by small sample sizes, variable age ranges and resulting inconsistent findings. There is a pressing need for large definitive studies to delineate the nature and extent of key case/control differences to direct research towards fruitful areas for future investigation. Here we focus on perception of biological motion, a promising index of social brain function which may be altered in ASD. In a large sample ranging from childhood to adulthood, we assess whether biological motion preference differs in ASD compared to neurotypical participants (NT), how differences are modulated by age and sex and whether they are associated with dimensional variation in concurrent or later symptomatology. METHODS: Eye-tracking data were collected from 486 6-to-30-year-old autistic (N = 282) and non-autistic control (N = 204) participants whilst they viewed 28 trials pairing biological (BM) and control (non-biological, CTRL) motion. Preference for the biological motion stimulus was calculated as (1) proportion looking time difference (BM-CTRL) and (2) peak look duration difference (BM-CTRL). RESULTS: The ASD group showed a present but weaker preference for biological motion than the NT group. The nature of the control stimulus modulated preference for biological motion in both groups. Biological motion preference did not vary with age, gender, or concurrent or prospective social communicative skill within the ASD group, although a lack of clear preference for either stimulus was associated with higher social-communicative symptoms at baseline. LIMITATIONS: The paired visual preference we used may underestimate preference for a stimulus in younger and lower IQ individuals. Our ASD group had a lower average IQ by approximately seven points. 18% of our sample was not analysed for various technical and behavioural reasons. CONCLUSIONS: Biological motion preference elicits small-to-medium-sized case–control effects, but individual differences do not strongly relate to core social autism associated symptomatology. We interpret this as an autistic difference (as opposed to a deficit) likely manifest in social brain regions. The extent to which this is an innate difference present from birth and central to the autistic phenotype, or the consequence of a life lived with ASD, is unclear. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13229-021-00476-0. BioMed Central 2021-12-15 /pmc/articles/PMC8672507/ /pubmed/34911565 http://dx.doi.org/10.1186/s13229-021-00476-0 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Mason, L. Shic, F. Falck-Ytter, T. Chakrabarti, B. Charman, T. Loth, E. Tillmann, J. Banaschewski, T. Baron-Cohen, S. Bölte, S. Buitelaar, J. Durston, S. Oranje, B. Persico, A. M. Beckmann, C. Bougeron, T. Dell’Acqua, F. Ecker, C. Moessnang, C. Murphy, D. Johnson, M. H. Jones, E. J. H. Preference for biological motion is reduced in ASD: implications for clinical trials and the search for biomarkers |
title | Preference for biological motion is reduced in ASD: implications for clinical trials and the search for biomarkers |
title_full | Preference for biological motion is reduced in ASD: implications for clinical trials and the search for biomarkers |
title_fullStr | Preference for biological motion is reduced in ASD: implications for clinical trials and the search for biomarkers |
title_full_unstemmed | Preference for biological motion is reduced in ASD: implications for clinical trials and the search for biomarkers |
title_short | Preference for biological motion is reduced in ASD: implications for clinical trials and the search for biomarkers |
title_sort | preference for biological motion is reduced in asd: implications for clinical trials and the search for biomarkers |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8672507/ https://www.ncbi.nlm.nih.gov/pubmed/34911565 http://dx.doi.org/10.1186/s13229-021-00476-0 |
work_keys_str_mv | AT masonl preferenceforbiologicalmotionisreducedinasdimplicationsforclinicaltrialsandthesearchforbiomarkers AT shicf preferenceforbiologicalmotionisreducedinasdimplicationsforclinicaltrialsandthesearchforbiomarkers AT falckyttert preferenceforbiologicalmotionisreducedinasdimplicationsforclinicaltrialsandthesearchforbiomarkers AT chakrabartib preferenceforbiologicalmotionisreducedinasdimplicationsforclinicaltrialsandthesearchforbiomarkers AT charmant preferenceforbiologicalmotionisreducedinasdimplicationsforclinicaltrialsandthesearchforbiomarkers AT lothe preferenceforbiologicalmotionisreducedinasdimplicationsforclinicaltrialsandthesearchforbiomarkers AT tillmannj preferenceforbiologicalmotionisreducedinasdimplicationsforclinicaltrialsandthesearchforbiomarkers AT banaschewskit preferenceforbiologicalmotionisreducedinasdimplicationsforclinicaltrialsandthesearchforbiomarkers AT baroncohens preferenceforbiologicalmotionisreducedinasdimplicationsforclinicaltrialsandthesearchforbiomarkers AT boltes preferenceforbiologicalmotionisreducedinasdimplicationsforclinicaltrialsandthesearchforbiomarkers AT buitelaarj preferenceforbiologicalmotionisreducedinasdimplicationsforclinicaltrialsandthesearchforbiomarkers AT durstons preferenceforbiologicalmotionisreducedinasdimplicationsforclinicaltrialsandthesearchforbiomarkers AT oranjeb preferenceforbiologicalmotionisreducedinasdimplicationsforclinicaltrialsandthesearchforbiomarkers AT persicoam preferenceforbiologicalmotionisreducedinasdimplicationsforclinicaltrialsandthesearchforbiomarkers AT beckmannc preferenceforbiologicalmotionisreducedinasdimplicationsforclinicaltrialsandthesearchforbiomarkers AT bougeront preferenceforbiologicalmotionisreducedinasdimplicationsforclinicaltrialsandthesearchforbiomarkers AT dellacquaf preferenceforbiologicalmotionisreducedinasdimplicationsforclinicaltrialsandthesearchforbiomarkers AT eckerc preferenceforbiologicalmotionisreducedinasdimplicationsforclinicaltrialsandthesearchforbiomarkers AT moessnangc preferenceforbiologicalmotionisreducedinasdimplicationsforclinicaltrialsandthesearchforbiomarkers AT murphyd preferenceforbiologicalmotionisreducedinasdimplicationsforclinicaltrialsandthesearchforbiomarkers AT johnsonmh preferenceforbiologicalmotionisreducedinasdimplicationsforclinicaltrialsandthesearchforbiomarkers AT jonesejh preferenceforbiologicalmotionisreducedinasdimplicationsforclinicaltrialsandthesearchforbiomarkers AT preferenceforbiologicalmotionisreducedinasdimplicationsforclinicaltrialsandthesearchforbiomarkers |